Zhiqiang Meng
Overview
Explore the profile of Zhiqiang Meng including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
188
Citations
4779
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ge D, Han C, Liu C, Meng Z
CNS Neurosci Ther
. 2025 Feb;
31(2):e70262.
PMID: 39963924
Background: Anesthesia is featured by behavioral and physiological characteristics such as decreased sensory and motor function, loss of consciousness, etc. Some anesthetics such as dexmedetomidine (DEX), induce electroencephalogram signatures close...
2.
Jiang S, Ge D, Song B, Deng X, Liu Z, He J, et al.
Neuropharmacology
. 2024 Dec;
265:110264.
PMID: 39675464
Anxiety, a common mental disorder, imposes significant clinical and economic burdens. Previous studies indicate that propofol has anxiolytic effects at anesthetic doses. However, the risks associated with general anesthesia limit...
3.
Yi L, Pan H, Ning Z, Xu L, Zhang H, Peng L, et al.
Signal Transduct Target Ther
. 2024 Dec;
9(1):347.
PMID: 39668159
Advanced biliary tract cancer (BTC) and pancreatic ductal adenocarcinoma (PDAC) have poor prognoses and limited treatment options. Here, we conducted this first-in-class phase II study to evaluate the efficacy and...
4.
Meng Z, Yan H, Wang Y
Sci Adv
. 2024 Dec;
10(49):eadq7933.
PMID: 39630910
Biological materials dynamically reconfigure their underlying structures in response to stimuli, achieving adaptability and multifunctionality. Conversely, mechanical metamaterials have fixed interunit connections that restrict adaptability and reconfiguration. This study introduces...
5.
Meng Z, Dong S
Hepatobiliary Surg Nutr
. 2024 Nov;
13(5):847-849.
PMID: 39507728
No abstract available.
6.
Li Q, Li Z, Chen B, Zhao J, Yu H, Hu J, et al.
Cell Rep
. 2024 Oct;
43(11):114893.
PMID: 39446586
RNA splicing is a critical process governing gene expression and transcriptomic diversity. Despite its importance, a detailed examination of transcript variation at the splicing junction level remains scarce. Here, we...
7.
Yan S, Meng Z, Liu W, Tan X, Cao P, Wen Y, et al.
Mater Horiz
. 2024 Oct;
11(24):6352-6360.
PMID: 39364611
Mechanical metamaterials for energy dissipation have received significant attention for vibration and impact mitigation. However, existing designs often neglect energy dissipation in the tensile direction, which is crucial for attenuating...
8.
Su Y, Li Z, Li Q, Guo X, Zhang H, Li Y, et al.
Theranostics
. 2024 Sep;
14(13):4948-4966.
PMID: 39267787
Tumor cells remodel transcriptome to construct an ecosystem with stemness features, which maintains tumor growth and highly malignant characteristics. However, the core regulatory factors involved in this process still need...
9.
Li J, Bai Y, Chen Z, Ying J, Guo Y, Fang W, et al.
Cancer Immunol Immunother
. 2024 Sep;
73(11):219.
PMID: 39235596
Background: Sitravatinib is a spectrum-selective tyrosine kinase inhibitor targeting TAM (TYRO3, AXL, MER), VEGFR-2, KIT, and MET. SAFFRON-104 (NCT03941873) was a multicohort phase Ib/II study investigating sitravatinib with/without tislelizumab, an...
10.
Liu B, Ye X, Fan W, Zhi X, Ma H, Wang J, et al.
J Cancer Res Ther
. 2024 Aug;
20(4):1109-1123.
PMID: 39206972
This expert consensus reviews current literature and provides clinical practice guidelines for the diagnosis and treatment of multiple ground glass nodule-like lung cancer. The main contents of this review include...